Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Clin Periodontol ; 40(12): 1104-11, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24118063

RESUMO

AIM: The aim of this study was to evaluate the effect of telmisartan (TELM) on inflammation, oxidation and the expression of matrix metalloproteinases (MMPs) and the expression RANKL/RANK/OPG in the periodontal tissue of a rat model for ligature-induced periodontitis. MATERIALS AND METHODS: Male Wistar albino rats were randomly divided into five groups of 10 rats each: (i) non-ligated, given water; (ii) ligated, given water; (iii) ligated, given 1 mg/kg TELM; (iv) ligated, given 5 mg/kg TELM; and (v) ligated, given 10 mg/kg TELM. All groups were treated with saline or TELM for 10 days. Periodontal tissue was analysed by histopathology; by the immunohistochemical examination of COX-2, MMP-2, MMP-9 and the RANKL/RANK/OPG pathway; and by ELISA analysis of the levels of IL-1ß, IL-10, TNF-α, myeloperoxidase (MPO), malonaldehyde (MDA) and glutathione (GSH). RESULTS: Treatment with 10 mg/kg TELM resulted in reduced concentrations of MPO, MDA (p < 0.05) and the pro-inflammatory cytokine IL-1ß (p < 0.05); reduced expression of MMP-2, MMP-9, RANK, RANKL and COX-2; and an increase in OPG. The levels of TNF-α were significantly reduced in all TELM-treated groups. CONCLUSIONS: These findings confirm the involvement of TELM in reducing the inflammatory response, oxidative stress and bone loss in ligature-induced periodontitis in rats.


Assuntos
Anti-Inflamatórios/uso terapêutico , Benzimidazóis/uso terapêutico , Benzoatos/uso terapêutico , Periodontite/tratamento farmacológico , Perda do Osso Alveolar/prevenção & controle , Animais , Antioxidantes/uso terapêutico , Ciclo-Oxigenase 2/metabolismo , Modelos Animais de Doenças , Regulação para Baixo , Glutationa/metabolismo , Interleucina-10/análise , Interleucina-1beta/metabolismo , Masculino , Malondialdeído/análise , Metaloproteinase 2 da Matriz/metabolismo , Metaloproteinase 9 da Matriz/metabolismo , Osteoprotegerina/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Periodontite/prevenção & controle , Peroxidase/metabolismo , Ligante RANK/metabolismo , Distribuição Aleatória , Ratos , Ratos Wistar , Receptor Ativador de Fator Nuclear kappa-B/metabolismo , Telmisartan , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA